HIT Consultant November 17, 2021
Jasmine Pennic

What You Should Know:

– Today Science 37 published a new report suggesting a momentous shift in the way that clinical trials are conducted.

– For the first time, more research sponsors and CROs are planning to run Agile/Hybrid Clinical Trials than ever before. Findings show that the vast majority or 77% of respondents plan to run an agile clinical trial in the next 12 months, compared to 59% for the previous 12 months.

Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37”), a LA-based pioneer of decentralization and Operating System for today’s more agile clinical trials™, has published new data suggesting that the clinical research industry has reached a pivotal shift in the way that clinical trials are conducted, as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas
New AI drug discovery powerhouse Xaira rises with $1B in funding
Moderna turns to AI to change how its employees work

Share This Article